story of the week
Heart Failure Risk Stratification and Efficacy of SGLT2 Inhibitors in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Circulation 2019 Aug 31;[EPub Ahead of Print], DD Berg, SD Wiviott, BM Scirica, Y Gurmu, O Mosenzon, SA Murphy, DL Bhatt, LA Leiter, DK McGuire, JPH Wilding, P Johanson, PA Johansson, AM Langkilde, I Raz, E Braunwald, MS SabatineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.